Bilaketaren emaitzak - MacLean Hall

  • Erakusten 1 - 9 emaitzak -- 9
Findu emaitzak
  1. 1
    Biomarkers on melanoma patient T Cells associated with ipilimumab treatment

    Biomarkers on melanoma patient T Cells associated with ipilimumab treatment nork Wenshi Wang, Daohai Yu, Amod A. Sarnaik, Bin Yu, MacLean Hall, Dawn Morelli, Yonghong Zhang, Xiuhua Zhao, Jeffrey S. Weber

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors

    Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors nork MacLean Hall, Hao Liu, Mokenge P. Malafa, Barbara A. Centeno, Pamela J. Hodul, José M. Pimiento, Shari Pilon‐Thomas, Amod A. Sarnaik

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

    Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy nork Kim H.T. Paraiso, Inna V. Fedorenko, Liliana Cantini, Ana Cecelia Munko, MacLean Hall, Vernon K. Sondak, Jane L. Messina, Keith T. Flaherty, Keiran S.M. Smalley

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

    Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma nork Amod A. Sarnaik, Bin Yu, Daohai Yu, Dawn Morelli, MacLean Hall, Dilip Bogle, Lulu Yan, Stephan Targan, Jolie C. Solomon, Geoff Nichol, Michael Yellin, Jeffrey S. Weber

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy

    Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy nork Patrick Innamarato, Krithika N. Kodumudi, Sarah Asby, Benjamin Schachner, MacLean Hall, Amy Mackay, Doris Wiener, Matthew Beatty, Luz Nagle, Ben Creelan, Amod A. Sarnaik, Shari Pilon‐Thomas

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function

    Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function nork John E. Mullinax, MacLean Hall, Matthew Beatty, Amy Weber, Zachary Sannasardo, Tanja Svrdlin, Jonathan A. Hensel, Marilyn M. Bui, Allison Richards, Ricardo González, Cheryl A. Cox, Linda Kelley, James J. Mulé, Amod A. Sarnaik, Shari Pilon‐Thomas

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

    Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma nork John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey S. Weber, Nikhil I. Khushalani, Zeynep Eroglu, Andrew S. Brohl, Joseph Markowitz, Erica Royster, Allison Richards, Valerie E. Stark, Jonathan S. Zager, Linda Kelley, Cheryl A. Cox, Vernon K. Sondak, James J. Mulé, Shari Pilon‐Thomas, Amod A. Sarnaik

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

    Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer nork Michael Poch, MacLean Hall, Autumn Joerger, Krithika N. Kodumudi, Matthew Beatty, Patrick Innamarato, Brittany Bunch, Mayer Fishman, Jingsong Zhang, Wade J. Sexton, Julio M. Pow‐Sang, Scott M. Gilbert, Philippe E. Spiess, Jasreman Dhillon, Linda Kelley, John E. Mullinax, Amod A. Sarnaik, Shari Pilon‐Thomas

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Neoantigen-specific CD4<sup>+</sup>tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

    Neoantigen-specific CD4<sup>+</sup>tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients nork MacLean Hall, Jamie K. Teer, Xiaoqing Yu, Holly Branthoover, Sebastian Snedal, Madeline Rodríguez-Valentín, Luz Nagle, Ellen Scott, Benjamin Schachner, Patrick Innamarato, Amy M Hall, Jamie Blauvelt, Carolyn J. Rich, Allison Richards, Jake Ceccarelli, TJ Langer, Sean Yoder, Matthew Beatty, Cheryl A. Cox, Jane L. Messina, Daniel Abate‐Daga, James J. Mulé, John E. Mullinax, Amod A. Sarnaik, Shari Pilon‐Thomas

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: